Next Article in Journal
Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
Next Article in Special Issue
Pharmacological Evaluation of 3-Carbomethoxy Fentanyl in Mice
Previous Article in Journal
Bioequivalence of Two Intravenous Artesunate Products with Its Active Metabolite Following Single and Multiple Injections
Previous Article in Special Issue
Fentanyl and Spiradoline Interactions in a Place-Conditioning Black-White Shuttle-Box
Open AccessReview

Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny

Department of Physiology & Pharmacology/Paediatrics, Faculty of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, T2N 4N1, Canada
Author to whom correspondence should be addressed.
Pharmaceuticals 2011, 4(1), 154-168;
Received: 9 December 2010 / Revised: 30 December 2010 / Accepted: 7 January 2011 / Published: 11 January 2011
(This article belongs to the Special Issue Opioids)
This review focuses on the physiological roles for kappa opioid receptors (KORs) in adult animals and humans, as well as in the developing newborn animal. Our recent findings have provided new information that under physiological conditions in conscious newborn animals, activation of KORs with the selective agonist, U-50488H, results in an aquaresis, as previously observed in adult animals and humans. In addition, we have shown in conscious lambs that KORs modulate systemic and renal haemodynamics as well as the arterial baroreflex control of heart rate, providing a previously unidentified role for KORs. View Full-Text
Keywords: kappa opioid peptides; KORs; newborn; physiology kappa opioid peptides; KORs; newborn; physiology
MDPI and ACS Style

Smith, F.G.; Qi, W. Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny. Pharmaceuticals 2011, 4, 154-168.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop